You just have to have other models, our DNA is different: the experiences of indigenous people who use illicit drugs and/or alcohol accessing substance use treatment

被引:17
|
作者
Lavalley, Jennifer [1 ]
Kastor, Shelda [2 ]
Tourangeau, Malcolm [2 ]
Goodman, Ashley [1 ]
Kerr, Thomas [1 ,3 ]
机构
[1] British Columbia Ctr Subst Use, 400-1045 Howe St, Vancouver, BC V6Z 2A9, Canada
[2] Western Aboriginal Harm Reduct Soc, Vancouver, BC, Canada
[3] Univ British Columbia, St Pauls Hosp, Dept Med, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada
基金
美国国家卫生研究院;
关键词
Indigenous peoples; Community-based participatory research; Decolonizing; Indigenous methodologies; Marginalized populations; Substance use treatment; TREATMENT ENTRY; CARE; OVERREPRESENTATION; CHILDREN; TRAUMA; WOMEN; RISK;
D O I
10.1186/s12954-020-00366-3
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objectives In Canada, and elsewhere, indigenous peoples who use illicit drugs and/or alcohol (IPWUID/A) commonly experience vulnerability and a disproportionate burden of harm related to substance use. In Vancouver, Canada, there are concerns that inequitable access, retention, and post treatment care within substance use treatment programs may exacerbate these harms. This study sought to understand the policies and practices with the potential to produce inequities and vulnerabilities for IPWUID/A in substance use treatment, situate the vulnerabilities of IPWUID/A in substance use treatment within the context of wider structural vulnerability of IPWUID/A, and generate recommendations for culturally safe treatment options. Methods This research employed a qualitative indigenous-led community-based approach using the indigenous methodology of talking circles to explore experiences with substance use treatment. Under the participatory research framework, community researchers led the study design, data collection, and analysis. Talking circles elicited peers' experiences of substance use treatment and were audio-recorded and transcribed. Results The talking circles identified three key themes that illustrated the experiences of IPWUID/A when accessing substance use treatment: (a) barriers to accessing detox and substance use treatment; (b) incompatible and culturally inappropriate structure, policies, and procedures within treatment programs, such as forced Christianity within treatment settings; and (c) the importance of culturally relevant, peer-led substance use treatment programming. Discussion Our work demonstrates that some IPWUID/A have limited access to or retention in mainstream treatment due to excessive waiting times, strict rules, and lack of cultural appropriate care while in treatment. However, IPWUID/A narratives revealed strategies that can improve IPWUID/A access and experiences, including those informed by the diverse perspectives of IPWUID/A and those that include trauma-informed and culturally safe practices.
引用
收藏
页数:10
相关论文
共 33 条
  • [31] Medical chart-reported alcohol consumption, substance use, and mental health issues in association with HIV pre-exposure prophylaxis (PrEP) nonadherence among gay, bisexual, and other men-who-have-sex-with-men
    Shuper, Paul A.
    Joharchi, Narges
    Varatharajan, Thepikaa
    Bogoch, Isaac I.
    Loutfy, Mona
    El-Helou, Philippe
    Giolma, Kevin
    Woodward, Kevin
    Rehm, Juergen
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [32] "It's a burden, it's a nuisance. I wish I didn't have these other ailments": a qualitative exploration of comorbidities management among older people living with HIV who use drugs in Vancouver, British Columbia
    Chayama, Koharu Loulou
    Ng, Cara
    Small, Will
    Ivsins, Andrew
    McNeil, Ryan
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 (10)
  • [33] Risk reduction through family therapy (RRFT): Protocol of a randomized controlled efficacy trial of an integrative treatment for co-occurring substance use problems and posttraumatic stress disorder symptoms in adolescents who have experienced interpersonal violence and other traumatic events
    Hahn, Austin M.
    Adams, Zachary W.
    Chapman, Jason
    McCart, Michael R.
    Sheidow, Ashli J.
    de Arellano, Michael A.
    Danielson, Carla Kmett
    CONTEMPORARY CLINICAL TRIALS, 2020, 93